Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVBO43A | — |
Menveo 2 vial expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVBO43A, expiry date 31-JUL-2025) for prophylaxis. On 14-AUG-2025, the patient received Menveo. On 14-AUG-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo 2 vial expired dose administration). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 15-AUG-2025 The reporter reported that he or she wanted to know how to proceed after giving an expired dose of Menveo 2 vial.